[ad_1]
The U.S. economy’s performance in the first three months of the year didn’t look much better the third time around: The government’s latest estimate of first-quarter annual growth was lifted slightly to a lackluster 1.4%.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...